Immunostimulating and Anti-cancer Effects of Pediococcus pentosaceus EROM101 isolated from Korea

Korean Journal of Microbiology and Biotechnology

Volumn 31, Issue 4, 2003, Pages 355-361

  Song, Mi Kyung ^a   Woo, Seok Gyu ^a   Jang, Jung Soon ^a   Kim, Jung Hak ^a   Kim, Hwa Young ^a   Hong, Seong Gil ^a   Lee, Byung Wook ^a   Park, Mi Hyun ^a   Chung, Kun Sub ^b  

^a Eromlife Co Ltd   (South Korea)

^b Yonsei University Wonju   (South Korea)

Author keywords

Anti cancer; Immunostimulant; Lactic acid bacteria; Pediococcus pentosaceus

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIUM ANTIBODY; CATALASE; EROM 101; IMMUNOGLOBULIN A; IMMUNOSTIMULATING AGENT; UNCLASSIFIED DRUG;

ANAEROBIC BACTERIUM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CANCER CELL CULTURE; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; EXPERIMENTAL MODEL; FEEDING; FERMENTATION; GRAM POSITIVE COCCI; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; KOREA; MACROPHAGE; MICROBIAL ACTIVITY; MOUSE; NONHUMAN; PEDIOCOCCUS; PEDIOCOCCUS PENTOSACEUS; PEYER PATCH; SARCOMA; SARCOMA CELL; SEA FOOD; SPLEEN CELL;

ANIMALIA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; LACTOBACILLUS; MURINAE; PEDIOCOCCUS; PEDIOCOCCUS PENTOSACEUS; POSIBACTERIA;

EID: 0347360440     PISSN: 1598642X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bogdanov, I.G., P.G. Dalev, A.I. Gurevich, M.N. Kolosov, V.P. Malekova, L.A. Plemyannikova, and I.B. Sorokina, 1975. Antitumour glycopeptides from Lactobacillus bulgaricus cell wall. FEBS Lett. 1: 259-261.
2. Sato, H., A. Yokosawa, H. Arai, H. Nagai, N. Kumano, M. Motomiya, and K. Konno. 1978. Antitumor activity of hot-water extract from delipidated BCG. Tohoku. J. Exp. Med. 125: 247-252.
3. Milas, L., B. Hunter, K. Mason, D. Grdina, and H. Withers. 1975. Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum. J. Natl. Cancer. Inst. 54: 895-902.
4. Proft, T., V.L. Arcus, V. Handley, E.N. Baker, and J.D. Fraser. 2001. Immunological and biochemical characterization of streptococeal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes. J. Immunol. 2001 166: 6711-6719.
5. Facklam, R. and J.A. Elliott. 1995. Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding the Streptococci and Enterococci. Clin. Microbiol. Rev. 8: 479-495.
6. Osmanagaoglu, O., Y. Beyatli, U. Gunduz, and S.C. Sacilik. 2000. Analysis of the genetic determinant for production of the pediocin P of Pediococcus pentosaceus Pep1. J. Basic. Microbiol. 40: 233-241.
7. de Ambrosini, V.M., S. Gonzalez, G. Perdigon, H.A.P. de Ruiz, and G. Oliver. 1996. Chemical composition of the cell wall of lactic acid bacteria and related species. Chem. Pharm. Bull. 44: 2263-2267.
8. Chae, O.W., K.S. Shin., H.W. Chung, and T.B. Choe. 1988. Immunostimulating effects of mice fed with cell lysate of Lactobacillus plantarum isolated from kimchi. Korean. J. Biotechnol. Bioeng. 13: 424-430.
9. Park, I.S. 1992. Function and phyiological characteristics of lactic acid bacteria isolated from kimchi. Ph.D. thesis. Chung-Ang Univ. Korea.
10. Yasutake, N., M. Ohwaki, M. Mutai, Y. Koide, and T. Yoshida. 1985. Anti-tumour effect of humoral and cellular immunities mediated by a bacterial immunopotentiator, Lactobacillus casei, in mice. Cancer. Immunol. Immunother. 20: 109-116.
11. Matsuzaki, T., T. Yokokura, and I. Azuma. 1987. Antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice. Cancer. Immunol. Immunother. 24: 99-105.
12. Kirjavainen, P.V., H.S. Elnezami, S.J. Salminen, J.T. Ahokas, and P.F.A. Wright. 1999. Effects of orally administrated viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. sheramnii JS on mouse lymphocyte proliferation. Clin. Diag. Lab. Immunol. 6: 799-802.
13. Takahashi, I. and H. Kiyono. 1999. Gut as the largest immunologic tissue. J. Parenter Enteral. Nutr. 23: S7-S12.
14. Isolauri, E., Y. Sutas, P. Kankaanpaa, H. Arvilommi, and S. Salminen. 2001. Probiotics: effects on immunity. Am. J. Clin. Nutr. 73: 444S-450S.
15. McGhee, J.R. and H. Kiyono. 1993. New perspectives in vaccine development: mucosal immunity to infections. Infect. Agents. Dis. 2: 55-73.
16. Takahashi, T., N.T. Nakagawa, T. Yajima, and T. Kuwata. 1998. Effects of orally ingested Bifidobacterium longum on the mucosal IgA response of mice to dietary antigens. Biosci. Biotechnol. Biochem. 62: 10-15.
17. Tejada-Simon, M.V., J.H. Lee, Z. Ustunol, and J.J. Pestka. 1999. Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiates immunoglobulin A responses to cholera toxin in mice. J. Dairy. Sci. 82: 649-660.
18. Kelkar, S.M., M.A. Shenoy, and G.S. Kaklij. 1988. Antitumor activity of lactic acid bacteria on a solid fibrosarcoma, sarcoma-180 and Ehrlich ascites carcinoma. Cancer Lett. 42: 73-77.
19. Kim, G.T., H. Bae, Y.J. Baek, and H.Y. Lee. 1994. Antitumor acitivity of Bifidobacterium adolesntis ATCC-15703 against Sarcoma 180 in mice. Kor. J. Appl. Microbiol. Biotechnol 22: 322-328.
20. Yoshida, J., S. Takamura, and S. Suzuki. 1991. Antitumor action of an acidic glycoprotein (SAGP) from Streptococcus pyogenes in mice. Biotherapy 3: 331-336.